Table 1 A Sample of GHQ-12 Threshold Studies on Various Clinical Populations after 1998
Author | Country | Sample | Threshold | Scoring |
|---|---|---|---|---|
Hardy [22] | England | Health care employees | 3/4 | GHQ-12 |
Kuruvilla [27] | India | Primary care patients | 2/3 | GHQ-12 |
Bhui [17] | England | Punjabi primary care patients | 2/3 | GHQ-12 |
Aydin [16] | Turkey | Tubercolosis and chronic obstructive pulmonary disease patients | 3/4 Tubercolosis 5/6 COPD | GHQ-12 |
Cano [18] | USA | Veterans | 1/2 | GHQ-12 |
Daradkeh [20] | UAE | Undergraduates | 15/16 | Likert |
Donath [21] | Australia | General population | 3/4 0/1 | C-GHQ GHQ-12 |
Makowska [29] | Poland | Working adults | 2/3 | GHQ-12 |
Holi [23] | Finland | General population | 3/4 | GHQ-12 |
McKenzie [31] | Australia | Gulf war veterans | 1/2 | GHQ-12 |
Picardi [33] | Italy | Dermatology patients | 3/4 | GHQ-12 |
Martin [30] | UK | Individuals with facial disfigurement | 0/1 | C-GHQ and GHQ-12 |
Navarro [32] | Spain | Postnatal women | 4/5 | GHQ-12 |
Schmitz [13] | Germany | Primary care patients | 11/12 | Likert |
Shelton [35] | England | Postnatal women | 4/5 14/15 | GHQ-12 Likert |
Krespi Boothby [26] | Turkey | Breast cancer patients | 1/2 affective disorders 1/2 generalised anxiety disorder 3/4 major depression | GHQ-12 |
Yusoff [36] | Malaysia | Medical students | 3/4 | GHQ-12 |
Baksheev [7] | Australia | High school students | 9/10 for males 10/11 for females | Likert |
Caraveo-Anduaga [19] | Mexico | Primary care patients | 2/3 | GHQ-12 |
Cornelius (2013) | The Netherlands | Disability claimants | 19/20 | Likert |
John [24] | India | General population | 3/4 | GHQ-12 |
Kim [25] | Korea | General population | 2/3 | GHQ-12 |
Lundin [28] | Sweden | General population | 11/12 5/6 1/2 | Likert C-GHQ GHQ-12 |
Ruiz [34] | Colombia | Undergraduates; female adults; psychiatric patients | 2/3 11/12 | GHQ-12 Likert |